SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-17-000349
Filing Date
2017-10-26
Accepted
2017-10-26 09:02:27
Documents
80
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K gnbt073117form10k.htm 10-K 1710688
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 18463
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 18185
4 EXHIBIT 32 ex32.htm EX-32 6853
5 GRAPHIC image_001.gif GRAPHIC 1557
  Complete submission text file 0001607062-17-000349.txt   5206267

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gnbt-20170731.xml EX-101.INS 603002
7 XBRL SCHEMA FILE gnbt-20170731.xsd EX-101.SCH 58936
8 XBRL CALCULATION FILE gnbt-20170731_cal.xml EX-101.CAL 43651
9 XBRL DEFINITION FILE gnbt-20170731_def.xml EX-101.DEF 210448
10 XBRL LABEL FILE gnbt-20170731_lab.xml EX-101.LAB 353379
11 XBRL PRESENTATION FILE gnbt-20170731_pre.xml EX-101.PRE 313059
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0320
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 171154913
SIC: 2834 Pharmaceutical Preparations